These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35955057)

  • 1. Real-Life Inter-Rater Variability of the PRAETORIAN Score Values.
    Budrejko S; Kempa M; Krupa W; Królak T; Fabiszak T; Raczak G
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.
    Quast ABE; Baalman SWE; Brouwer TF; Smeding L; Wilde AAM; Burke MC; Knops RE
    Heart Rhythm; 2019 Mar; 16(3):403-410. PubMed ID: 30292861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.
    Francia P; Biffi M; Adduci C; Ottaviano L; Migliore F; De Bonis S; Dello Russo A; De Filippo P; Viani S; Bongiorni MG; Caravati F; Lavalle C; Landolina ME; Pisanò E; Giorgi D; Lovecchio M; Valsecchi S; Diemberger I
    Europace; 2020 Dec; 22(12):1822-1829. PubMed ID: 33118017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of posture on position of subcutaneous implantable cardioverter-defibrillator.
    Pepplinkhuizen S; Spijkerboer AM; van der Stuijt W; de Veld JA; Dijkshoorn LA; Stenchlak ZE; Reijerink MAA; de Weger A; Smeding L; Olde Nordkamp LRA; Wilde AAM; Knops RE
    Heart Rhythm; 2024 Aug; ():. PubMed ID: 39103135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial.
    Knops RE; El-Chami MF; Marquie C; Nordbeck P; Quast ABE; Tilz RR; Brouwer TF; Lambiase PD; Cassidy CJ; Boersma LVA; Burke MC; Pepplinkhuizen S; de Veld JA; de Weger A; Bracke FALE; Manyam H; Probst V; Betts TR; Bijsterveld NR; Defaye P; Demming T; Elders J; Field DC; Ghani A; Golovchiner G; de Jong JSSG; Lewis N; Marijon E; Martin CA; Miller MA; Shaik NA; van der Stuijt W; Kuschyk J; Olde Nordkamp LRA; Arya A; Borger van der Burg AE; Boveda S; van Doorn DJ; Glikson M; Kaiser L; Maass AH; van Woerkens LJPM; Zaidi A; Wilde AAM; Smeding L
    Heart Rhythm; 2024 Jun; 21(6):836-844. PubMed ID: 38336193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    Yamazaki K; Ishida Y; Sasaki S; Toyama Y; Nishizaki K; Kinjo T; Itoh T; Kimura M; Sakai S; Shikanai S; Sorimachi Y; Hamaura S; Tomita H
    J Cardiol; 2022 Nov; 80(5):482-486. PubMed ID: 35902323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the PRAETORIAN score in a large subcutaneous implantable cardioverter-defibrillator collective: Usefulness in clinical routine.
    Doldi F; Frommeyer G; Löher A; Ellermann C; Wolfes J; Güner F; Zerbst M; Engelke H; Korthals D; Reinke F; Eckardt L; Willy K
    Heart Rhythm; 2024 Jul; 21(7):1057-1063. PubMed ID: 38382685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients.
    Hoster C; Rahman A; Goyal A; Peigh G; Trohman R; Knight BP; Huang H; Krishnan K; Larsen T; Mazur A; Sharma P; Engelstein E; Verma N; Wasserlauf J
    J Interv Card Electrophysiol; 2023 Jan; ():. PubMed ID: 36596954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study.
    Forleo GB; Gasperetti A; Breitenstein A; Laredo M; Schiavone M; Ziacchi M; Vogler J; Ricciardi D; Palmisano P; Piro A; Compagnucci P; Waintraub X; Mitacchione G; Carrassa G; Russo G; De Bonis S; Angeletti A; Bisignani A; Picarelli F; Casella M; Bressi E; Rovaris G; Calò L; Santini L; Pignalberi C; Lavalle C; Viecca M; Pisanò E; Olivotto I; Curnis A; Dello Russo A; Tondo C; Love CJ; Di Biase L; Steffel J; Tilz R; Badenco N; Biffi M
    Heart Rhythm; 2021 Dec; 18(12):2072-2079. PubMed ID: 34214647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
    Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
    Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprocedural PRAETORIAN score for early assessment of S-ICD implantation: A proof-of-concept study.
    Gasperetti A; Schiavone M; Biffi M; Casella M; Compagnucci P; Mitacchione G; Angeletti A; Vogler J; Proietti R; Ziacchi M; Dello Russo A; Natale A; Tilz RR; Forleo GB
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3035-3041. PubMed ID: 34582055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing elevated subcutaneous implantable cardioverter-defibrillator defibrillation thresholds: The importance of implantation technique.
    Ip JE
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1205-1208. PubMed ID: 33484227
    [No Abstract]   [Full Text] [Related]  

  • 16. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique.
    Okabe T; Savona SJ; Matto F; Ward C; Singh P; Afzal MR; Kalbfleisch SJ; Weiss R; Houmsse M; Augostini RS; Hummel JD; Daoud EG
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3027-3034. PubMed ID: 34554620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications related to elective generator replacement of the subcutaneous implantable defibrillator.
    van der Stuijt W; Quast ABE; Baalman SWE; de Wilde KC; Brouwer TF; Wilde AAM; Knops RE
    Europace; 2021 Mar; 23(3):395-399. PubMed ID: 33197266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PRAETORIAN score: guardian against subcutaneous implantable cardioverter-defibrillator shock failure?
    Boersma LVA
    Europace; 2020 Dec; 22(12):1761-1762. PubMed ID: 33236073
    [No Abstract]   [Full Text] [Related]  

  • 20. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.